BACKGROUND: Acute disseminated encephalomyelitis (ADEM) is a demyelinating disorder of the central nervous system (CNS). Differentiating ADEM from other inflammatory disorders, such as multiple sclerosis, is not always conclusive using conventional MRI. OBJECTIVE: To evaluate longitudinal magnetic resonance spectroscopy (MRS) changes that distinguish ADEM from other inflammatory disorders. MATERIALS AND METHODS: MRI/MRS scans were performed in seven patients with ADEM during the acute and chronic phases of the disease. RESULTS: Partial recovery was detected between the acute and chronic phases in choline/creatine ratio. Major elevation of lipids and reduction in myo-inositol/creatine ratio was detected in all patients during the acute phase, followed by a reduction in lipids peak and elevation above normal in myo-inositol/creatine ratio during the chronic phase. CONCLUSION: Consistent and unique MRS changes in metabolite ratios between the acute and chronic presentations of the disease were found. To the best of our knowledge, these patterns have not been described in other inflammatory disorders and might assist in the early diagnosis of ADEM.
BACKGROUND:Acute disseminated encephalomyelitis (ADEM) is a demyelinating disorder of the central nervous system (CNS). Differentiating ADEM from other inflammatory disorders, such as multiple sclerosis, is not always conclusive using conventional MRI. OBJECTIVE: To evaluate longitudinal magnetic resonance spectroscopy (MRS) changes that distinguish ADEM from other inflammatory disorders. MATERIALS AND METHODS: MRI/MRS scans were performed in seven patients with ADEM during the acute and chronic phases of the disease. RESULTS: Partial recovery was detected between the acute and chronic phases in choline/creatine ratio. Major elevation of lipids and reduction in myo-inositol/creatine ratio was detected in all patients during the acute phase, followed by a reduction in lipids peak and elevation above normal in myo-inositol/creatine ratio during the chronic phase. CONCLUSION: Consistent and unique MRS changes in metabolite ratios between the acute and chronic presentations of the disease were found. To the best of our knowledge, these patterns have not been described in other inflammatory disorders and might assist in the early diagnosis of ADEM.
Authors: R Mark Wellard; Regula S Briellmann; James W Prichard; Ari Syngeniotis; Graeme D Jackson Journal: Epilepsia Date: 2003-06 Impact factor: 5.864
Authors: P A Brex; G J Parker; S M Leary; P D Molyneux; G J Barker; C A Davie; A J Thompson; D H Miller Journal: J Neurol Neurosurg Psychiatry Date: 2000-05 Impact factor: 10.154
Authors: Sarah Gheuens; Long Ngo; Xiaoen Wang; David C Alsop; Robert E Lenkinski; Igor J Koralnik Journal: Neurology Date: 2012-08-22 Impact factor: 9.910
Authors: Muhamed N H Eeza; Rico Singer; Corinna Höfling; Jörg Matysik; Huub J M de Groot; Steffen Roβner; A Alia Journal: J Alzheimers Dis Date: 2021 Impact factor: 4.472